CMS to stop requiring states to report childhood vaccination levels
On Jan. 2, 2026, U.S. states will no longer be required to report how many children they vaccinate…
US measles outbreak tops 2,000 known infections
On Dec. 29, 2025, measles cases nationwide have reached 2,012, the Centers for Disease Control and Prevention (CDC)…
WHO reported Middle East respiratory syndrome coronavirus outbreak continues
On Dec. 24, 2025, the World Health Organization (WHO) reported that since the beginning of 2025 and as…
FDA approves Novo Nordisk’s Wegovy® pill, the first and only oral GLP-1 for weight loss in adults
On Dec. 22, 2025, Novo Nordisk announced announced that the US Food and Drug Administration (FDA) has approved…
Scientists Map the Human Genome in 4D
On Dec. 22, 2025, scientists at Northwestern University announced a landmark effort to understand how the physical structure…
Biotechnology | CMO | CRO | Genomics | Therapeutics | Vaccine
Samsung Biologics Expands U.S. Manufacturing Capabilities with Acquisition of Human Genome Sciences from GSK
On Dec. 21, 2025, Samsung Biologics announced that its wholly owned U.S. subsidiary, Samsung Biologics America, has entered…
FDA Announces Approval of Cytokinetics’ MYQORZO™ (aficamten) for Treatment of Adults with Symptomatic Obstructive Hypertrophic Cardiomyopathy
On Dec. 19, 2025, Cytokinetics announced that the U.S. Food and Drug Administration (FDA) has approved MYQORZO™ (aficamten),…
Biotechnology | COVID-19 | Diagnostics | Genomics | Infectious Disease | Influenza | Measles | Plague | Polio | Vaccine
A century of emergence: trends and patterns in human viral pathogens, 1900–2024, a systematic review
On Dec. 20, 2025, a new study published in the journal BMC Infectious Diseases reported that viral emergence…
Novartis and U.S. government reach agreement on lowering drug prices
On Dec. 19, 2025, Novartis, a leading global innovative medicines company, announced it has reached an agreement with…
BioMarin to Acquire Amicus Therapeutics for $4.8 Billion, Expanding Position as a Leader in Rare Diseases
On Dec. 19, 2025, BioMarin Pharmaceutical and Amicus Therapeutics announced that BioMarin has entered into a definitive agreement…
CRISPR primes goldenberry for fruit bowl fame
On Dec. 19, 2025, Cold Spring Harbor Laboratory (CSHL) plant biologists may have found a “shortcut” to this…
Biotechnology | Diagnostics | HIV | Therapeutics | Vaccine | WHO | Women's Health
WHO validates Brazil for eliminating mother-to-child transmission of HIV
On Dec. 18, 2025, the World Health Organization (WHO) announced it has validated Brazil for the elimination of…
Chronic Disease Could Cost the U.S. $47 Trillion Over Next 15 Years
On Dec. 18, 2025, new national and state data was released by the Partnership to Fight Chronic Disease…
Space Station Research Supports New FDA-Approved Cancer Therapy
On Dec. 18, 2025, the National Aeronautics and Space Administration (NASA) announced it has opened the International Space…
Novo Nordisk files for FDA approval of CagriSema, the first once-weekly combination of GLP‑1 and amylin analogues for weight management
On Dec. 18, 2025, Novo Nordisk announced the submission of a New Drug Application (NDA) to the U.S….
Israeli, US scientists uncover viral switch that could help defeat antibiotic resistance
On Dec. 18, 2025, scientists at the Hebrew University of Jerusalem revealed that bacteriophages use a small RNA…
WHO Releases Statement on the antigen composition of COVID-19 vaccines
On Dec. 18, 2025, the World Health Organization (WHO) Technical Advisory Group on COVID-19 Vaccine Composition (TAG-CO-VAC) announced…
How common is Alzheimer’s? Blood-test study holds surprises
On Dec. 17, 2025, A survey of Alzheimer’s disease prevalence in Norway confirms earlier estimates and might show…
Detailed cell map unlocks secrets of how reproductive organs form
On Dec. 17, 2025, new research has mapped the cell types that specialise to form reproductive organs in…
University Engineers create robots barely visible to the naked eye that operate autonomously
On Dec. 17, 2025, researchers at the University of Pennsylvania’s (UPenn) School of Engineering and Applied Science, and…
CDC | COVID-19 | Diagnostics | Genomics | Infectious Disease | Influenza | Measles | Vaccine
Harsh Flu Season May Be Driven by New Variant K
On Dec. 16, 2025, researchers from the International Vaccines Access Center (IVAC) reported that as of mid-December, flu,…
US NIH races to fill nearly half its top roles after wave of departures
On Dec. 15, 2025, the U.S. National Institutes of Health is seeking to fill nearly half of its…
Adaptive Inks deals with Pfizer to support research in rheumatoid arthritis and other immune-related diseases woth $890 Million
On Dec. 15, 2025, Adaptive Biotechnologies announced it has signed two non-exclusive deals with Pfizer to support research…
GigaTIME AI tool advances cancer research and could unlock access to better treatment
On Dec. 15, 2025, Microsoft Research announced a new AI tool developed by and published in Cell allows…
National Science Foundation softens grant-review rules to cope with backlog
On Dec. 15, 2025, the U.S. National Science Foundation (NSF) is relaxing some of its requirements for the…
Biotechnology | CDC | Diagnostics | Infectious Disease | Influenza | USDA | Vaccine
Highly Pathogenic Avian Influenza Detected in Shelby County Commercial Flock
On Dec. 12, 2025, the Texas Animal Health Commission (TAHC) and the United States Department of Agriculture’s (USDA)…
Biotechnology | Disease | FDA | Therapeutics
FDA Approves Two Oral Therapies to Treat Gonorrhea
On Dec. 12, 2025, the U.S. Food and Drug Administration (FDA) announced it has approved two new oral…
Flu, RSV activity rising in US and Europe, with major UK surge in flu cases
On Dec. 12, 2025, the Center for Infectious Disease Research & Policy (CIDRAP) reported COVID-19 rates in the…
Hundreds are quarantined in South Carolina as measles spreads in 2 US outbreaks
On Dec. 11, 2025, measles outbreaks are growing along the Utah-Arizona border and in South Carolina, where hundreds…
Biotechnology | Cardiology | Clinical Research | CRISPR | Disease | Non-Profit Research | Oncology | Rare Disease | Therapeutics
CIRM approves over $160M to support preclinical and clinical research, advances education opportunities and access to clinical trials
On Dec. 11, 2025, the California Institute for Regenerative Medicine (CIRM) governing board approved funding of over $160…